Transitioning Women With Human Immunodeficiency Virus to First-Line Preferred Regimen of Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir in Sub-Saharan Africa

Simple item page
dc.contributor.authorShah, Neha
dc.contributor.authorAgaba, Patricia
dc.contributor.authorIroezindu, Michael
dc.contributor.authorBahemana, Emmanuel
dc.contributor.authorKibuuka, Hannah
dc.contributor.authorPolyak, Christina S.
dc.contributor.authorAke, Julie A.
dc.date.accessioned2023-03-06T20:32:11Z
dc.date.available2023-03-06T20:32:11Z
dc.date.issued2022
dc.description.abstractIn 2019, the World Health Organization (WHO) recommended combined tenofovir disoproxil fumarate, lamivudine, and dolutegravir (TLD) as the preferred first-line regimen for adults and adolescents with human immunodeficiency virus (HIV), regardless of childbearing status. Nevertheless, final eligibility is determined by local policies, which may vary from WHO recommendations. We examined TLD transition by sex across 5 HIV care programs in sub-Saharan Africa supported by the United States President's Emergency Plan for AIDS Relief (PEPFAR).en_US
dc.identifier.citationShah, N., Esber, A., Cavanaugh, J. S., Agaba, P., Dear, N., Iroezindu, M., ... & Tanzania, M. (2022). Transitioning Women With Human Immunodeficiency Virus to First-Line Preferred Regimen of Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir in Sub-Saharan Africa. Clinical Infectious Diseases.https://doi.org/10.1093/cid/ciac555en_US
dc.identifier.issn1537-6591
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/8096
dc.language.isoenen_US
dc.publisherClinical Infectious Diseasesen_US
dc.subjectDolutegraviren_US
dc.subjectHuman Immunodeficiency Virusen_US
dc.subjectTenofovir Disoproxil Fumarateen_US
dc.titleTransitioning Women With Human Immunodeficiency Virus to First-Line Preferred Regimen of Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir in Sub-Saharan Africaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Transitioning Women With Human Immunodeficiency Virus to First-Line Preferred Regimen of Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir in Sub-Saharan Africa.pdf
Size:
741.04 KB
Format:
Adobe Portable Document Format
Description:
Transitioning Women With Human Immunodeficiency Virus to First-Line Preferred Regimen of Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir in Sub-Saharan Africa
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences